What's New

May 9, 2025

LEIE Database Updated with April 2025 Exclusions and Reinstatements

Updated: Corporate Integrity Agreements

Updated: CMP and Affirmative Exclusions/EMTALA Patient Dumping

Updated: Fraud Self-Disclosures

May 7, 2025

Most Medicare Part D Plans’ Formularies Included Humira Biosimilars for 2025 OEI-05-23-00520

Enforcement Actions

May 13, 2025; U.S. Department of Justice

New Hampshire Doctor Pleads Guilty to Illegally Prescribing Opioids

May 9, 2025; U.S. Attorney's Office, Middle District of Louisiana

Three Baton Rouge Individuals Plead Guilty In Federal Court In Connection With The Department Of Justice’s 2024 National Health Care Fraud Enforcement Action

May 9, 2025; U.S. Department of Justice

Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay $3.6M to Resolve Allegations that It Violated the False Claims Act in Connection with Marketing its Fentanyl Product

What's Trending

1. Potential Cost Savings in HHS Programs: Legislative Actions
2. Fraud Alert: Genetic Testing Scam
3. City of Grand Junction Agreed to Pay $25,000 for Allegedly Violating the Civil Monetary Penalties Law by Submitting Claims for Transport Services Provided by Individuals with Expired Certifications
4. Featured Topic: The Emergency Medical Treatment and Labor Act (EMTALA)
5. Trend Toward More Expensive Inpatient Hospital Stays in Medicare Emerged Before COVID-19 and Warrants Further Scrutiny